| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Sven Jarius, Christian Lechner, Eva M Wendel, Matthias Baumann, Markus Breu, Mareike Schimmel, Michael Karenfort, Adela Della Marina, Andreas Merkenschlager, Charlotte Thiels, Astrid Blaschek, Michela Salandin, Steffen Leiz, Frank Leypoldt, Alexander Pschibul, Annette Hackenberg, Andreas Hahn, Steffen Syrbe, Jurgis Strautmanis, Martin Häusler, Peter Krieg, Astrid Eisenkölbl, Johannes Stoffels, Matthias Eckenweiler, Ilya Ayzenberg, Jürgen Haas, Romana Höftberger, Ingo Kleiter, Mirjam Korporal-Kuhnke, Marius Ringelstein, Klemens Ruprecht, Nadja Siebert, Kathrin Schanda, Orhan Aktas, Friedemann Paul, Markus Reindl, Brigitte Wildemann, Kevin Rostás. Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: Results from 108 lumbar punctures in 80 pediatric patients. Journal of neuroinflammation. vol 17. issue 1. 2021-07-21. PMID:32883358. |
new-generation, cell-based assays have demonstrated a robust association of serum autoantibodies to full-length human myelin oligodendrocyte glycoprotein (mog-igg) with (mostly recurrent) optic neuritis, myelitis, and brainstem encephalitis, as well as with neuromyelitis optica (nmo)-like or acute-disseminated encephalomyelitis (adem)-like presentations. |
2021-07-21 |
2023-08-13 |
human |
| Andres Server Alonso, Tomas Sakinis, Helle Cecilie V Pfeiffer, Inger Sandvig, Jon Barlinn, Pål B Marthinse. Understanding Pediatric Neuroimmune Disorder Conflicts: A Neuroradiologic Approach in the Molecular Era. Radiographics : a review publication of the Radiological Society of North America, Inc. vol 40. issue 5. 2021-07-14. PMID:32735475. |
the authors focus on pediatric-onset myelin oligodendrocyte glycoprotein (mog) antibody-associated disease, which is a new entity in the spectrum of inflammatory demyelinating diseases, distinct from both multiple sclerosis (ms) and anti-aquaporin-4 (aqp4) antibody neuromyelitis optica spectrum disorders (nmosds). |
2021-07-14 |
2023-08-13 |
Not clear |
| Shunsuke Yoshimura, Shinsuke Nakagawa, Toshiyuki Takahashi, Keiko Tanaka, Akira Tsujin. FTY720 Exacerbates Blood-Brain Barrier Dysfunction Induced by IgG Derived from Patients with NMO and MOG Disease. Neurotoxicity research. vol 39. issue 4. 2021-07-13. PMID:33999356. |
neuromyelitis optica (nmo) and myelin oligodendrocyte glycoprotein (mog) antibody-related disease (mog disease) are inflammatory demyelinating diseases of the central nervous system (cns). |
2021-07-13 |
2023-08-13 |
rat |
| Matthew C Mason, Dario A Marotta, Hassan Kesserwan. Isolated Double-Positive Optic Neuritis: A Case of Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibody Seropositivity. Cureus. vol 13. issue 6. 2021-07-13. PMID:34249541. |
neuromyelitis optica (nmo) and myelin oligodendrocyte glycoprotein antibody disease (mogad) are the usual causes of acute severe sequential or simultaneous bilateral optic neuritis. |
2021-07-13 |
2023-08-13 |
Not clear |
| Fiona Costello, John J Che. The role of optical coherence tomography in the diagnosis of afferent visual pathway problems: A neuroophthalmic perspective. Handbook of clinical neurology. vol 178. 2021-07-09. PMID:33832689. |
on a more pragmatic level, oct is used in the clinical arena to diagnose on associated with: ms, neuromyelitis optica spectrum disorder (nmosd), and myelin oligodendrocyte glycoprotein (mog) antibody associated disease (mogad). |
2021-07-09 |
2023-08-13 |
Not clear |
| Bo Chen, Chuan Qin, Suqiong Ji, Daishi Tian, Min Zhang, Bitao B. Modified models to distinguish central nervous system demyelinating diseases with brain lesions. Multiple sclerosis and related disorders. vol 52. 2021-07-06. PMID:33905981. |
brain lesions in patients with myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) are indistinguishable from those with relapsing-remitting multiple sclerosis (rrms) and aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (aqp4-ab nmosd). |
2021-07-06 |
2023-08-13 |
Not clear |
| Sidney M Gospe, John J Chen, M Tariq Bhatt. Neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein associated disorder-optic neuritis: a comprehensive review of diagnosis and treatment. Eye (London, England). vol 35. issue 3. 2021-07-05. PMID:33323985. |
neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein associated disorder-optic neuritis: a comprehensive review of diagnosis and treatment. |
2021-07-05 |
2023-08-13 |
Not clear |
| Sidney M Gospe, John J Chen, M Tariq Bhatt. Neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein associated disorder-optic neuritis: a comprehensive review of diagnosis and treatment. Eye (London, England). vol 35. issue 3. 2021-07-05. PMID:33323985. |
however, the discovery of aquaporin-4 immunoglobulin g (igg) and myelin oligodendrocyte glycoprotein (mog)-igg as biomarkers for two separate central nervous system inflammatory demyelinating diseases has revealed that neuromyelitis optica spectrum disorder (nmsod) and mog-igg-associated disease (mogad) are responsible for clinically distinct subsets of on. |
2021-07-05 |
2023-08-13 |
Not clear |
| Jacqueline F Rosenthal, Benjamin M Hoffman, William R Tyo. CNS inflammatory demyelinating disorders: MS, NMOSD and MOG antibody associated disease. Journal of investigative medicine : the official publication of the American Federation for Clinical Research. vol 68. issue 2. 2021-07-02. PMID:31582425. |
neuromyelitis optica spectrum disorder (nmosd) and myelin oligodendrocyte glycoprotein (mog) antibody-associated disease are less common but share some clinical characteristics, such as optic neuritis and myelitis, which can make a specific diagnosis challenging. |
2021-07-02 |
2023-08-13 |
Not clear |
| Rachid Belfkih, Omar Ghomari Khayat, Hind H'daidane, Fatima Zahra El Amran. Pseudotumoral Demyelinating Lesions: A Presentation of Acute Disseminated Encephalomyelitis. Case reports in neurology. vol 13. issue 2. 2021-06-29. PMID:34177535. |
these lesions could also be seen in myelin oligodendrocyte glycoprotein antibody-associated demyelination, acute disseminated encephalomyelitis (adem), and neuromyelitis optica spectrum disorder. |
2021-06-29 |
2023-08-13 |
Not clear |
| Amy Kunchok, John J Chen, Ruba S Saadeh, Dean M Wingerchuk, Brian G Weinshenker, Eoin P Flanagan, Sean J Pittoc. Application of 2015 Seronegative Neuromyelitis Optica Spectrum Disorder Diagnostic Criteria for Patients With Myelin Oligodendrocyte Glycoprotein IgG-Associated Disorders. JAMA neurology. vol 77. issue 12. 2021-06-24. PMID:32777005. |
application of 2015 seronegative neuromyelitis optica spectrum disorder diagnostic criteria for patients with myelin oligodendrocyte glycoprotein igg-associated disorders. |
2021-06-24 |
2023-08-13 |
Not clear |
| Pawan T Ojha, Vikram B Aglave, Girish Soni, Kamlesh A Jagiasi, Rakesh K Singh, Rakeshsingh Kamleshsingh Singh, Shashank Nagendr. Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-Associated CNS Demyelination: Clinical Spectrum and Comparison with Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder. Neurology India. vol 68. issue 5. 2021-05-25. PMID:33109860. |
myelin oligodendrocyte glycoprotein (mog) antibody-associated cns demyelination: clinical spectrum and comparison with aquaporin-4 antibody positive neuromyelitis optica spectrum disorder. |
2021-05-25 |
2023-08-13 |
Not clear |
| Qin Du, Ziyan Shi, Hongxi Chen, Ying Zhang, Jiancheng Wang, Yuhan Qiu, Zhengyang Zhao, Qin Zhang, Hongyu Zho. Comparison of clinical characteristics and prognoses in patients with different AQP4-Ab and MOG-Ab serostatus with neuromyelitis optica spectrum disorders. Journal of neuroimmunology. vol 353. 2021-05-25. PMID:33515897. |
at present, patients positive for aquaporin-4 antibody (aqp4-ab) or myelin oligodendrocyte glycoprotein antibody (mog-ab) are diagnosed as neuromyelitis optica spectrum disorder (nmosd) and mog-ab-associated diseases, respectively. |
2021-05-25 |
2023-08-13 |
Not clear |
| John R Ciotti, Noah S Eby, Gregory F Wu, Robert T Naismith, Salim Chahin, Anne H Cros. Clinical and laboratory features distinguishing MOG antibody disease from multiple sclerosis and AQP4 antibody-positive neuromyelitis optica. Multiple sclerosis and related disorders. vol 45. 2021-05-14. PMID:32702642. |
antibodies to myelin oligodendrocyte glycoprotein (mog) are associated with a cns inflammatory disorder distinct from multiple sclerosis (ms) and aquaporin-4 antibody-positive neuromyelitis optica (nmo). |
2021-05-14 |
2023-08-13 |
Not clear |
| J Rigal, G Pugnet, J Ciron, Z Lépine, D Biott. Off-label use of tocilizumab in neuromyelitis optica spectrum disorders and MOG-antibody-associated diseases: A case-series. Multiple sclerosis and related disorders. vol 46. 2021-05-14. PMID:32942119. |
the objective of the study was to evaluate the indication, efficacy and safety of tocilizumab, a humanized anti-interleukin-6 receptor antibody, in patients with neuromyelitis optica spectrum disorders (nmosd) and myelin oligodendrocyte glycoprotein antibody associated diseases (mogad) encountered in current neurological practice. |
2021-05-14 |
2023-08-13 |
Not clear |
| Shabeer Paul, Gouranga Prasad Mondal, Ramesh Bhattacharyya, Kartik Chandra Ghosh, Imtiyaz Ahmad Bha. Neuromyelitis optica spectrum disorders. Journal of the neurological sciences. vol 420. 2021-05-14. PMID:33272591. |
the disease concept of neuromyelitis optica spectrum disorders(nmosd) has undergone a significant change over the last two decades including the detection of myelin oligodendrocyte glycoprotein(mog) antibody in patients who are seronegative for aquaporin-4 antibody. |
2021-05-14 |
2023-08-13 |
Not clear |
| Paul M Elsbernd, William R Hoffman, Jonathan L Carter, Dean M Wingerchu. Interleukin-6 inhibition with tocilizumab for relapsing MOG-IgG associated disorder (MOGAD): A case-series and review. Multiple sclerosis and related disorders. vol 48. 2021-05-14. PMID:33360264. |
myelin oligodendrocyte glycoprotein-immunoglobulin g (mog-igg) associated disorder (mogad) is a cns demyelinating disease distinct from neuromyelitis optica spectrum disorder (nmosd) and multiple sclerosis. |
2021-05-14 |
2023-08-13 |
Not clear |
| Juliane Weber, Nora Bernsdorff, Tilman Robinson, Dominique Endres, Sebastian Rauer, Benjamin Berge. Diagnosis of multiple sclerosis in times of MOG and AQP4 autoantibody testing - A monocentric study. Journal of the neurological sciences. vol 421. 2021-05-14. PMID:33360733. |
myelin oligodendrocyte glycoprotein-igg-associated encephalomyelitis (mog-em) and neuromyelitis optica spectrum disorders are challenging differential diagnoses of multiple sclerosis (ms). |
2021-05-14 |
2023-08-13 |
Not clear |
| Edgar Carnero Contentti, Pablo A Lopez, Juan Pablo Pettinicchi, Agustín Pappolla, Jimena Miguez, Liliana Patrucco, Edgardo Cristiano, Carlos Vrech, Verónica Tkachuk, Susana Liwacki, Jorge Correale, Mariano Marrodan, María I Gaitán, Marcela Fiol, Laura Negrotto, María C Ysrraelit, Marcos Burgos, Felisa Leguizamon, Dario Tavolini, Norma Deri, Maria E Balbuena, Carolina Mainella, Geraldine Luetic, Patricio Blaya, Javier Hryb, María L Menichini, Amelia Alvez Pinheiro, Pedro Nofal, Gisela Zanga, Andrés Barboza, Ivan Martos, Luciana Lazaro, Ricardo Alonso, Emanuel Silva, Santiago Bestoso, Maria E Fracaro, Adriana Carrá, Orlando Garcea, Nora Fernandez Liguori, Marina Alonso Serena, Alejandro Caride, Juan I Roja. What percentage of AQP4-ab-negative NMOSD patients are MOG-ab positive? A study from the Argentinean multiple sclerosis registry (RelevarEM). Multiple sclerosis and related disorders. vol 49. 2021-05-14. PMID:33454601. |
myelin oligodendrocyte glycoprotein antibodies (mog-ab) have been described in aquaporin-4-antibodies(aqp4-ab)-negative neuromyelitis optica spectrum disorder (nmosd) patients. |
2021-05-14 |
2023-08-13 |
Not clear |
| Silvia Messina, Romina Mariano, Ruth Geraldes, Su-Hyun Kim, Chanjira Satukijcha, Domizia Vecchio, Yi Yi Chua, James Taylor, Naveen George, Ana Cavey, Alejandro Rubio Diaz, Sandra Reeve, Rosie Everett, Gabriele De Luca, Maria Isabel Leite, Ho Jin Kim, Jacqueline Palac. The influence of smoking on the pattern of disability and relapse risk in AQP4-positive Neuromyelitis Optica Spectrum Disorder, MOG-Ab Disease and Multiple Sclerosis. Multiple sclerosis and related disorders. vol 49. 2021-05-14. PMID:33540279. |
to assess the effect of smoking on relapses and disability in neuromyelitis optica with aquaporin-4-antibodies (nmosd-aqp4-ab), myelin oligodendrocyte glycoprotein-antibodies associated disease (mogad) and relapsing remitting multiple sclerosis (ms) patients. |
2021-05-14 |
2023-08-13 |
Not clear |